focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtalaya Mining Regulatory News (ATYM)

Share Price Information for Atalaya Mining (ATYM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 460.00
Bid: 457.00
Ask: 460.00
Change: 7.00 (1.55%)
Spread: 3.00 (0.656%)
Open: 459.00
High: 466.00
Low: 455.00
Prev. Close: 453.00
ATYM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Slovakian Exploration Licences Update

22 Dec 2014 10:00

RNS Number : 4365A
EMED Mining Public Limited
22 December 2014
 

22 December2014

EMED Mining Public Limited

("EMED Mining" or the "Company")

 

Slovakian Exploration Licences Update

 

EMED Mining Public Limited, the Europe-based minerals development and exploration company, announces that it has entered into a conditional earn-in agreement (the "Earn-in Agreement") with Prospech Ltd ("Prospech"), a private Australian exploration company, in relation to the exploration licences in the Hodrusa-Hamre-Banska Stiavnica and Velke Pole districts of Slovakia (the "Slovakian Properties") held by EMED's 100% owned Slovakian subsidiary, Slovenske Kovy s.r.o. ("SLOK").

Prospech will invest up to a €1 million over a three year period in return for an 81% interest in SLOK. The monies invested by Prospech will be used to fund exploration on the Slovakian Properties. Of the initial €200,000 investment, €86,000 will be paid to EMED for access to the Slovakian Properties database. The Earn in agreement is conditional, inter alia, on Prospech raising €200,000 to fund the first phase of exploration. The Earn in Agreement will terminate if it does not become unconditional on or before 31 March 2015.

The exploration licences, which occur in a region with a mining history over 1,000 years and recorded production of 2.4M ounces of gold and 120M ounces of silver, have great potential for epithermal vein style, high grade mineralisation that can be mined by underground mining methods and processing techniques that do not use cyanide, i.e. by gravity and flotation.

The parties will enter into a joint venture agreement which will provide that, in the event that EMED dilutes to 5% or less in SLOK and a bankable feasibility study of a discovery recommends commencement of mining, EMED will have the option to convert its interest to a net smelter royalty at the rate of 1.0% for a 5% interest (or pro rata for an interest less than 5%). Prospech shall have a call option to buy out the net smelter royalty for an amount and in a timeframe to be agreed.

 

Isaac Querub, CEO of EMED Mining said:"We are pleased to be able to reach an agreement with a partner to help develop SLOK. Given our focus on the restart of Proyecto Riotinto, which is progressing rapidly towards production, the transaction has been structured so that EMED retains some upside without the need to dedicate resources to what has become a non-core asset."

Enquiries

EMED Mining

Ronnie Beevor/ Isaac Querub/ Alberto Lavandeira Adan

+34 959 59 28 50

Canaccord Genuity

Neil Elliot/Mark Palmer

+44 207 523 8000

Fox-Davies Capital

Oliver Stansfield

+44 203 463 5061

Walbrook PR

Nick Rome

+44 207 933 8783

 

For further information on the Company's activities, visit www.emed-mining.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKLLBLZLFEFBK
Date   Source Headline
8th May 20247:00 amRNSNotice of Q1 2024 Financial Results
7th May 20247:00 amRNSExercise of Share Options
7th May 20247:00 amRNSPublication of 2023 Sustainability Documents
29th Apr 20244:32 pmRNSHolding(s) in Company
29th Apr 20248:00 amRNSReadmission - ATALAYA MINING PLC
29th Apr 20247:00 amRNSAdmission to Trading on the Main Market
26th Apr 20245:00 pmRNSHolding(s) in Company
24th Apr 202412:51 pmRNSPublication of Prospectus
11th Apr 20247:00 amRNSQ1 2024 Operations Update
19th Mar 20247:00 amRNS2023 Annual Results
8th Mar 20247:00 amRNSNotice of 2023 Annual Results
9th Feb 20247:00 amRNSIssue of Equity
18th Jan 20247:00 amRNSQ4 Operations Update and 2024 Production Guidance
21st Dec 20237:01 amRNSUpdate on Move to Main Market
21st Dec 20237:00 amRNSHolding(s) in Company
21st Dec 20237:00 amRNSHolding(s) in Company
20th Dec 20237:00 amRNSHolding(s) in Company
14th Dec 20231:49 pmRNSExtension of Port Handling Agreement
12th Dec 202311:28 amRNSResults of the 2023 Extraordinary General Meeting
12th Dec 20237:00 amRNS2023 Extraordinary General Meeting Statement
1st Dec 20237:00 amRNSHistorical Related Party Transactions
20th Nov 20237:00 amRNSHolding(s) in Company
16th Nov 20237:00 amRNSQ3 and YTD 2023 Financial Results
14th Nov 20237:00 amRNSProposed Re-domiciliation and Notice of EGM
13th Nov 20237:00 amRNSIntention to Move from AIM to Main Market
2nd Nov 20237:00 amRNSNotice of Q3 and YTD 2023 Financial Results
12th Oct 20237:00 amRNSQ3 2023 Operations Update
10th Oct 20233:11 pmRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSInterim Dividend Foreign Exchange Rates
10th Aug 20237:00 amRNSQ2 and H1 2023 Financial Results
27th Jul 20237:00 amRNSNotice of Q2 and H1 2023 Financial Results
20th Jul 20237:00 amRNSFinal Dividend Foreign Exchange Rates & Payment
20th Jul 20237:00 amRNSCorrection to Q2 Provisional Revenue Adjustments
12th Jul 20237:00 amRNSQ2 2023 Operations Update
10th Jul 20237:00 amRNSPDMR Shareholding
29th Jun 20237:00 amRNS2022 Final Dividend Timetable
28th Jun 202311:25 amRNSResults of the 2023 Annual General Meeting
28th Jun 20237:00 amRNS2023 Annual General Meeting Statement
26th Jun 20237:00 amRNSReport on Payments to Governments
26th Jun 20237:00 amRNSApproval to Cease to be Reporting in Canada
1st Jun 20237:00 amRNSNotice of AGM
30th May 20237:00 amRNSApplication to Cease to be a Reporting Issuer
23rd May 20237:00 amRNSGrant of Share Options and PDMR Notification
16th May 20237:00 amRNSPublication of 2022 Sustainability Report
15th May 20237:00 amRNSQ1 2023 Financial Results
2nd May 20237:00 amRNSNotice of Q1 2023 Results
17th Apr 20237:00 amRNSQ1 2023 Operations Update
28th Mar 20237:00 amRNSEnvironmental Authorisation Granted to PMV
24th Mar 20237:00 amRNSFiling of New Riotinto PEA Technical Report
23rd Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.